Our mission is educating, outreach and advocating for individuals, and the families of those diagnosed with Prostate Cancer. To save lives across the populations through education on cancer prevention, and early detection. We provide tools to help teach family and friends how to support loved ones in their effort to overcome challenges from diagnoses thru recovery.

Our Mission is to STOP...the worries of those diagnose with Prostate Cancer before It STARTS!

Prostate cancer is the most common non-skin cancer among men in the United States. Every year more than 230,000 men are diagnosed with the disease, and approximately 30,000 die from it. If detected early, prostate cancer is often treatable. The five-year relative survival rate is nearly 100 percent and at 15 years it’s 94 percent.

Teacher of Men provides consultation services to the general population, with an additional on focus on members of, first responders police, fire fighters and EMTs and military (active, reserve and national guard).

We assist by providing real life experience on dealing with, defeating prostate cancer.

With the group or private sessions offered, we provide first-hand knowledge and support while on your personal journey dealing with prostate cancer.

Keith E Dodley - Owner, President

Tyler K Dodley - Vice President, Board Member, Treasurer

Kevin Dodley, VP Operations, Board Member

Mike Martin – VP Planning, Board Member

Rick Greene – Board Member

Robert Havener – Board Member

Kristopher Boyce - IT Support

Providing service throughout Ohio. Our goal is to educate and support those individuals, and their families, who have been diagnosed with prostate cancer. We will provide the tools that help teach family and friends how to support loved ones in their effort to overcome challenges. We will equip all parties with the necessary knowledge needed to handle each new life situation one day at a time. We will work to provide a place of refuge as we assist with upcoming life-changing events

Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men

BACKGROUND—Prostate-specific antigen screening has profoundly affected the epidemiology

of prostate cancer in the United States. Persistent racial disparities in outcomes for Black men

warrant re-examination of the harms of screening relative to its cancer-specific mortality benefits

in this population.

We estimated overdiagnoses and overtreatment of prostate cancer for men of all races and for Black men 50 to 84 years of age until 2016, the most recent year with treatment data available, using excess incidence relative to 1986 based on the Surveillance, Epidemiology, and End Results registry and U.S. Census data as well as an established microsimulation model of prostate cancer natural history. Combining estimates with plausible mortality benefit, we calculated numbers needed to diagnose (NND) and treat (NNT) to prevent one prostate cancer death.

RESULTS—For men of all races, we estimated 1.5 to 1.9 million (range between estimation approaches) overdiagnosed and 0.9 to 1.5 million overtreated prostate cancers by 2016. Assuming that half of the 270,000 prostate cancer deaths avoided by 2016 were attributable to screening, the NND and the NNT would be 11 to 14 and 7 to 11 for men of all races and 8 to 12 and 5 to 9 for

Black men, respectively. Alternative estimates incorporating a lag between incidence and mortality resulted in a NND and a NNT for Black men that reached well into the low single digits.

• Some men are at a higher risk for developing prostate cancer:

o African American men have the highest incidence of prostate cancer; they are 60 percent more likely to develop the disease and more than twice as likely to die from it compared to Caucasian men

o Men with a family history of prostate cancer are at higher risk for developing prostate cancer

o Men who served in the military during the Vietnam and Korean wars who were exposed to Agent Orange are at a higher risk for developing prostate cancer (and other cancers/diseases)

• Approximately 27,000 men will die this year from prostate cancer (74 men every day); prostate cancer is the second largest cancer killer of men following lung cancer

• If detected early, prostate cancer is often treatable

• Screening for prostate cancer includes a PSA (prostate specific antigen) blood test and a DRE (digital rectal exam); a biopsy is required to diagnose prostate cancer

•. Nearly 3 million men in the U.S. are living with a prostate cancer diagnosis; that number is estimated to climb to 4 million by 2024 as men in the baby boomer generation age

• Rather than any “quick fix” for prostate cancer, there are many treatment options and related side effects that each patient needs to evaluate

Monthly Meetings (3rd Sat)

Contact : Keith Dodley

Email : teacherofmen@gmail.com

Phone:614-301-3104